A. Kotch

The tidal volume response to incremental exercise in COPD.

C. A. Vaz Fragoso, T. Clark, A. Kotch, 1993, Chest.

Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin

R. S. Sen, M. Schluchter, George W. Williams, 1998 .

A 35-year-old woman with asthma and polycystic lung disease.

M. Walker, A. Kotch, V. Rella, 2002, Chest.

Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study.

A. Kotch, C. Reisner, G. Dworkin, 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD.

J. Karpel, A. Kotch, M. Zinny, 1994, Chest.

Comparison of volume output from two different continuous nebulizer systems.

J. Lee, A. Kotch, C. Reisner, 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Idiopathic pulmonary haemosiderosis revisited

A. Kotch, O. Ioachimescu, S. Sieber, 2004, European Respiratory Journal.

Idiopathic Pulmonary Hemosiderosis in Adults

J. Stoller, A. Kotch, O. Ioachimescu, 2005, Pneumologia.

Eosinophilic pneumonia as a presentation of occult chronic granulomatous disease.

R. Matthay, R. Homer, D. Trawick, 1997, The European respiratory journal.

Lower Back Pain and Sleep: Mattresses, Sleep Quality and Daytime Symptoms

Y. Amoateng-Adjepong, C. Manthous, F. Roux, 2007 .

Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.

E. Bleecker, M. Sackner, N. Gross, 1986, The American journal of medicine.

Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD.

M. Ghafouri, K. Rice, T. Witek, 2001, Chest.